Immuneering Corporation
IMRX
$6.74
$0.050.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.68% | 4.07% | 16.65% | -23.66% | -3.68% |
| Total Depreciation and Amortization | -6.10% | -0.86% | -0.86% | -3.01% | -1.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.14% | -9.32% | 1.13% | 4.09% | -2.60% |
| Change in Net Operating Assets | -58.67% | 464.08% | -153.35% | 357.27% | -190.77% |
| Cash from Operations | -26.80% | 32.91% | 2.96% | -7.71% | -16.88% |
| Capital Expenditure | -247.62% | 76.40% | 5.32% | -77.36% | 83.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 201.66% | -208.20% |
| Cash from Investing | -247.62% | 76.40% | -100.16% | 201.39% | -209.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10,298,328.57% | -99.98% | 15,884.49% | -98.02% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,704.53% | -- | -- | -- | -- |
| Cash from Financing | 343,958.23% | -100.45% | 33,784.39% | -100.94% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,215.70% | -3,308.67% | 96.92% | 37.61% | -121.43% |